The hepatitis B virus HBx protein inhibits caspase 3 activity.


The hepatitis B virus-encoded HBx protein coactivates transcription of viral and cellular genes, and it is believed to play an important role in hepatitis B virus-related liver cancer. HBx has been shown to alter the coordinated balance between proliferation and programmed cell death, being able to either induce or block apoptosis. Here, we demonstrate for the first time that the HBx is a potent caspase 3 inhibitor. Rat fibroblasts (REV2) and hepatoma cells (Hep) synthesizing the HBx protein were resistant to various apoptotic stimuli such as growth factor depletion, tumor necrosis factor alpha, or anti-Fas antibodies administration. In these cells, HBx prevented DNA fragmentation and cell death in the absence of de novo protein synthesis, with a similar efficiency as the competitive caspase 3 substrates inhibitors VAD-FMK and DEVD-FMK. Protein extracts obtained from the HBx positive cells contained a very low caspase activity, and addition of anti-HBx antibody restored the endogenous caspase activity. To obtain a functional map of the anti-caspase activity of HBx, various cell lines were established that synthesized either N-terminally or C-terminally truncated HBx molecules. These gene dissection experiments revealed that the regions required for the anti-caspase activity overlap with the two known transactivation domains of HBx.


Citations per Year

1,191 Citations

Semantic Scholar estimates that this publication has 1,191 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Gottlob1998TheHB, title={The hepatitis B virus HBx protein inhibits caspase 3 activity.}, author={Kathrin Gottlob and Marcella Fulco and Massimo Levrero and Adolf Graessmann}, journal={The Journal of biological chemistry}, year={1998}, volume={273 50}, pages={33347-53} }